Atrial fibrillation (AF) is the most common sustained arrhythmia with an estimated
prevalence in adults as high as 4%. AF negatively affects the quality of life and
it is associated with incident adverse cardiovascular events and two-fold higher mortality.
Lifetime risk of AF increases with age but many other risk factors such as diabetes,
chronic kidney disease, hypertension and obesity may promote its development. Owing
to the shared risk factors, AF and coronary artery disease (CAD) can both be found
in the same patient at some point in life [
[1]
].To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Atrial fibrillation and the risk of myocardial infarction.JAMA Intern Med. 2014; 174: 107-114
- Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation.J Cardiol. 2015; 66: 148-154
- Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.JAMA. 1994; 271: 840-844
- Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls.Heart Rhythm. 2012; 9: 1923-1929
- Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in communities (ARIC) study.Circulation. 2015; 131: 1843-1850
- Troponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart review.Int J Emerg Med. 2011; 4: 25
- Etiology of minor troponin elevations in patients with atrial fibrillation at emergency department-Tropo-AF study.J Clin Med. 2019; 8
- The risk for acute coronary syndrome associated with atrial fibrillation among ED patients with chest pain syndromes.Am J Emerg Med. 2007; 25: 523-528
- Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation.J Am Coll Cardiol. 1997; 30: 1039-1045
- Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.Eur Heart J. 2002; 23: 734-741
- Myocardial perfusion is impaired and relates to cardiac dysfunction in patients with atrial fibrillation both before and after successful catheter ablation.J Am Heart Assoc. 2018; 7e009218
- Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke.Circulation. 2002; 106: 2854-2858
- Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of trends.Heart Rhythm. 2011; 8: 1416-1423
- Prognostic value of isolated troponin I elevation after percutaneous coronary intervention.Circ Cardiovasc Interv. 2010; 3: 431-435
- Frequency, determinants and outcome of elevated troponin in acute ischemic stroke patients.Int J Cardiol. 2012; 157: 239-242
- Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry.Eur J Intern Med. 2022; 99: 45-56https://doi.org/10.1016/j.ejim.2022.01.025
Article info
Publication history
Published online: February 06, 2022
Accepted:
February 2,
2022
Received:
January 30,
2022
Identification
Copyright
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registryEuropean Journal of Internal MedicineVol. 99
- PreviewCardiac troponins (cTn) are the preferred biomarkers for the detection of myocardial injury and the diagnosis of myocardial infarction (MI) [1–3]. However, with the advent of high-sensitivity (hs)-cTn assays, elevated levels of cTn may be a common finding in daily clinical practice even in several non-ischaemic, acute or chronic conditions, such as heart failure (HF), chronic kidney disease (CKD), sepsis, inflammatory diseases, etc. [4–10].
- Full-Text
- Preview
